Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06019182 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MEHMO Natural History and Biomarkers

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 213 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor 6 versions Re-verified since Jul 16, 2025, no change to tracked fieldsv208-v213
  2. Minor Study description shortened, about 44 wordsv207
  3. Minor 2 versions Re-verified since Apr 3, 2025, no change to tracked fieldsv205-v206
  4. Minor Start date: Apr 24, 2024 to Oct 23, 2023v204
  5. Minor 2 versions Re-verified since Dec 27, 2024, no change to tracked fieldsv202-v203
Show 38 earlier versionsHide 38 earlier versions
  1. Minor Eligibility criteria expanded, about 7 wordsv201
  2. Minor 2 versions Re-verified since Jul 26, 2024, no change to tracked fieldsv199-v200
  3. Minor Start date changed from estimate of Jul 30, 2024 to Apr 24, 2024v198
  4. Minor Start date: Jul 29, 2024 to Jul 30, 2024v197
  5. Minor Start date: Jul 28, 2024 to Jul 29, 2024v196
  6. Minor Start date: Jul 25, 2024 to Jul 28, 2024v195
  7. Minor Start date: Jul 24, 2024 to Jul 25, 2024v194
  8. Minor Start date: Jul 23, 2024 to Jul 24, 2024v193
  9. Minor Start date: Jul 22, 2024 to Jul 23, 2024v192
  10. Minor Start date: Jul 21, 2024 to Jul 22, 2024v191
  11. Minor Start date: Jul 18, 2024 to Jul 21, 2024v190
  12. Minor Start date: Jul 17, 2024 to Jul 18, 2024v189
  13. Minor Start date: Jul 15, 2024 to Jul 17, 2024v188
  14. Minor Start date: Jul 14, 2024 to Jul 15, 2024v187
  15. Minor Start date: Jul 11, 2024 to Jul 14, 2024v186
  16. Minor Start date: Jul 9, 2024 to Jul 11, 2024v185
  17. Minor Start date: Jul 8, 2024 to Jul 9, 2024v184
  18. Minor Start date: Jul 7, 2024 to Jul 8, 2024v183
  19. Minor Start date: Jul 4, 2024 to Jul 7, 2024v182
  20. Minor Start date: Jul 3, 2024 to Jul 4, 2024v181
  21. Minor Start date: Jul 2, 2024 to Jul 3, 2024v180
  22. Minor Start date: Jul 1, 2024 to Jul 2, 2024v179
  23. Minor Start date: Jun 30, 2024 to Jul 1, 2024v178
  24. Minor Start date: Jun 27, 2024 to Jun 30, 2024v177
  25. Minor Start date: Jun 26, 2024 to Jun 27, 2024v176
  26. Minor Start date: Jun 23, 2024 to Jun 26, 2024v175
  27. Minor Start date: Jun 20, 2024 to Jun 23, 2024v174
  28. Minor Start date: Jun 19, 2024 to Jun 20, 2024v173
  29. Minor Start date: Jun 18, 2024 to Jun 19, 2024v172
  30. Minor Start date: Jun 17, 2024 to Jun 18, 2024v171
  31. Minor Start date: Jun 16, 2024 to Jun 17, 2024v170
  32. Minor Start date: Jun 13, 2024 to Jun 16, 2024v169
  33. Minor Start date: Jun 12, 2024 to Jun 13, 2024v168
  34. Minor Start date: Jun 11, 2024 to Jun 12, 2024v167
  35. Minor Start date: Jun 10, 2024 to Jun 11, 2024v166
  36. Minor Start date: Jun 9, 2024 to Jun 10, 2024v165
  37. Minor Start date: Jun 6, 2024 to Jun 9, 2024v164
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This observational natural history study will follow individuals with MEHMO (Mental disability, Epileptic seizure, Hypopituitarism/Hypogenitalism, Microcephaly, Obesity) syndrome or an eIF2-pathway related disorder, who have symptoms such as intellectual delay, seizures, abnormal hormone and blood sugar levels, and decreased motor skills. No current treatment for these conditions is available. A major impediment to the testing of potential therapeutic interventions is the lack of well-defined outcome measures. This protocol seeks to identify biochemical and clinical markers to monitor disease progression, and better understand the natural history of these conditions. Any person diagnosed with MEHMO syndrome or related conditions, who can travel to the NIH Clinical Center can participate in this study. The study involves: * General health assessment and evaluation * Imaging studies * Laboratory tests * Collection of blood, urine, spinal fluid, skin biopsy.
Trial Details
NCT Number NCT06019182
Lead Sponsor Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions
(from sponsor)
Intellectual Disability, Epilepsy, Hypogonadisms, Microcephaly, Nervous System Malformations, Obesity
Related terms Epilepsy, Intellectual Disability, MEHMO syndrome, Microcephaly, Nervous System Malformations, Obesity
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov